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journal homepage: ht tp: / /www.elsevier .com/locate/al i tEditorialAllergens in modern society: Updated catalogs and future prospectsIn Allergology International (AI) Vol. 64 No. 4, we offer a set of re-
view articles entitled “Allergens in modern society: Updated cata-
logs and future prospects” as well as original articles and letters
to the editor. We believe that this review series will provide you
with the latest concepts in the area of allergens.
Allergen components, which are molecules recognized by spe-
ciﬁc IgE antibodies found in patients with allergic diseases, are
capable of inducing allergic symptoms. Organisms such as house
dust mites (HDM) and fungi or substances such as house dust,
HDM fecal pellets, pollen, food, and cat dander, all of which produce
or contain allergen components, are called allergen sources. These
allergen sources are frequently particles containing not only
allergen components but also many different biologically active
substances. The term “allergen” generally refers to the “allergen
component” or “allergen source.” Knowing about allergens and
how we encounter them in modern society is essential for under-
standing allergic diseases.
The review series “Allergens in modern society: Updated cata-
logs and future prospects” includes ﬁve articles. The ﬁrst one is a
thoughtful overview of allergens,1 and the following four are
comprehensive reviews of allergens derived from HDM,2 Japanese
cedar pollen (JCP),3 fungi,4 and foods,5 respectively. They provide
reliable maps useful for research and development for molecular
diagnosis (component-resolved diagnosis, CRD) as well as for
new therapeutic approaches.
Woodfolk et al. review essential knowledge about allergens,
emphasizing the importance of sources, particles, and routes of
exposure as well as the molecular properties of the allergens.1
They discuss how and why allergic diseases have increased in
“post-hygiene” countries over the last 100 years. Their review
also considers oligosaccharide IgE epitopes such as a-1,3-
galactose6 present on the monoclonal antibody cetuximab and in
red meat.
Wayne R. Thomas provides the latest comprehensive review of
HDM allergens.2 In the 1960s, HDMs were found to be the main
allergen source contained in house dust. In the 1980s, the cDNA
encoding Der p 1 was cloned. Recently, Der p 23 was identiﬁed as
a new serodominant allergen,2 and the Dermatophagoides farinae
draft genomewas determined.7 This article arranges the HDM aller-
gens of more than 30 groups into four classes and provides updated
information.
Fujimura and Kawamoto offer an update of JCP allergens and
describe the impact of CRD on pollen allergy.3 Tree pollens of thePeer review under responsibility of Japanese Society of Allergology.
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cause allergic diseases in East Asia, the Mediterranean, and the
United States. In Japan, the prevalence of JCP pollinosis dramatically
increased in the past half-century, to the point where it is now
considered a “national affliction.”8
Fukutomi and Taniguchi review fungal allergens and their
species-speciﬁc clinical relevance.4 Numbers of species of fungi
are associated with allergic diseases. The contribution of fungi to
allergic diseases is species speciﬁc, varying according to the route
and episode of exposure. CRD using allergen molecules but not ex-
tracts has been suggested to conquer the problem in diagnosis
caused by broad inter-species IgE cross-reactivity.9
Matsuo et al. present a current review of food allergens and their
IgE epitopes.5 The importance of extra-intestinal, such as epicuta-
neous, routes of sensitization to food allergens as the cause of epi-
demics of food allergy has been suggested.1,10 In diagnosis and
therapy, IgEs speciﬁc to allergen components or epitope peptides
are good indicators for identifying patients, predicting clinical
severity, and monitoring tolerance induction.
Among the contributors to this issue, Odajima et al. reported the
results of a multi-center, open-label study of administration of
omalizumab, an anti-IgE antibody, io Japanese childrenwith severe
allergic asthma.11 Omalizumab is prescribed to adult asthma pa-
tients worldwide. However, its use in children (6e<12 years) has
been thus far approved only in the EU.12 Seventeen centers in Japan,
led by Odajima, conducted this study targeting 38 Japanese chil-
dren with uncontrolled severe allergic asthma consistent with
step 4 treatment of the JPGL2008 over a 24-week treatment period.
Omalizumab showed good efﬁcacy, with improved scores for
asthma symptoms, daily activity, and nocturnal sleep. It also
showed a decrease in the rates of asthma exacerbation and hospi-
talization due to asthma as well as a reduction in the dose of any
asthma controller medications. This study shows the usefulness
of omalizumab for treatment of asthma children also in Japan.
Tabalipa et al. surveyed the socioeconomic factors related to
hospitalization for bronchial asthma in Brazil.13 In addition to
well-known environmental factors for bronchial asthma such as
trafﬁc pollution and exposure to cigarette smoke, several social fac-
tors such as neighborhood problems and lack of family support are
shown to be associated with incidence of asthma in young peo-
ple.14,15 Tabalipa et al. analyzed the association between several
public indexes and the admission rates due to bronchial asthma
in all Brazilian municipalities, ﬁnding that admission rates are asso-
ciated with low levels of employment, income, education, and
health as well as with a high homicide rate. These results suggestvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Editorial / Allergology International 64 (2015) 293e294294that social deterioration can be a risk factor for hospital admissions
due to asthma.
We offer our appreciation to all the authors for their contribu-
tions to the present issue of Allergology International.
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